Fact CheckerSign in

NCT07417904Recruiting

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Young Adults and Violent Behavior During Early Psychosis (Aim 3)

Source: ClinicalTrials.gov · Last updated 29 Jul 2026

Brief summary (registry, in English)

This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
2 Feb 2026
Start date
2 Jul 2026
Primary completion date
Aug 2027
Lead sponsor
Howard University
NCT number
NCT07417904

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 2 Jul 2026 to the primary completion date, Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of antisocial behavior, as assessed at baseline

Other

  • Unable to provide informed consent
  • Not fluent in English
  • Immediate risk requiring a higher level of care

Who the study is looking for

  • Young adults aged 16-30 years
  • Diagnosis of early psychosis
  • Currently receiving outpatient care through an early psychosis clinic
  • Psychiatrically stable and deemed appropriate for participation by a treating clinician
  • Able and willing to provide informed consent

Age in the registry: 16 years to 30 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Howard University Hospital
Coordinator of this site? Confirm its status
Washington D.C.United StatesNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.